谷歌浏览器插件
订阅小程序
在清言上使用

A Spotlight on Drug-Induced Vasculitis.

Current Rheumatology Reports(2022)

引用 7|浏览2
暂无评分
摘要
Purpose of Review Drug-induced vasculitis (DIV) is a rare form of vasculitis related to the use of various drugs. DIV primarily affects small to medium size vessels, but it can potentially involve vessels of any size. Differentiating between primary systemic vasculitis and DIV can be challenging; however, it is crucial, so that the offending agent can be discontinued promptly. Recent Findings The clinical phenotype of DIV is protean and depends on the size of the affected vessels. It ranges from arthralgias, to an isolated cutaneous rash, to severe single or multi-organ involvement. While withdrawal of the offending drug is the most important step in management, a significant number of patients require immunosuppressive therapy for varying periods of time. Summary DIV can affect any vascular bed size, leading to protean vasculitic syndromes. Increased awareness among general practitioners, specialty, and subspecialty physicians is crucial for early recognition, and withdrawal of drug for better outcomes.
更多
查看译文
关键词
Drug-induced vasculitis (DIV),Drug-induced ANCA-associated vasculitis,Hydralazine,Cocaine,Propylthiouracil,Tumor necrosis factor-α (TNF-α),Minocycline,Immune checkpoint inhibitors (ICIs),Granulocyte colony-stimulating factor (G-CSF)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要